These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 25065024)

  • 1. Clinical aspects of cytochrome P4502E1 (CYP2E1) which is a potent source of oxidative stress. Preface.
    Subcell Biochem; 2013; 67():vii-ix. PubMed ID: 25065024
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytochrome P450 2E1: its clinical aspects and a brief perspective on the current research scenario.
    Dey A
    Subcell Biochem; 2013; 67():1-104. PubMed ID: 23400917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease.
    Kathirvel E; Morgan K; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):973-83. PubMed ID: 19307976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
    Wu D; Cederbaum A
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of DNA strand breaks and oxidative stress in HeLa cells by ethanol is dependent on CYP2E1 expression.
    Hodges NJ; Green RM; Chipman JK; Graham M
    Mutagenesis; 2007 May; 22(3):189-94. PubMed ID: 17284772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2E1 autoantibodies in liver diseases.
    Sutti S; Rigamonti C; Vidali M; Albano E
    Redox Biol; 2014; 3():72-8. PubMed ID: 25462068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taurine and liver diseases: a focus on the heterogeneous protective properties of taurine.
    Miyazaki T; Matsuzaki Y
    Amino Acids; 2014 Jan; 46(1):101-10. PubMed ID: 22918604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2E1 potentiates toxicity in obesity and after chronic ethanol treatment.
    Cederbaum AI
    Drug Metabol Drug Interact; 2012; 27(3):125-44. PubMed ID: 23104821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oxidative stress and liver disease].
    Blázovics A
    Orv Hetil; 2004 Sep; 145(38):1937-42. PubMed ID: 15535104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 2E1 and hyperglycemia-induced liver injury.
    Dey A; Kumar SM
    Cell Biol Toxicol; 2011 Aug; 27(4):285-310. PubMed ID: 21455816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells.
    Nieto N; Friedman SL; Greenwel P; Cederbaum AI
    Hepatology; 1999 Oct; 30(4):987-96. PubMed ID: 10498651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in the protein and mRNA levels of CYP2E1 and CYP3A isoforms as well as in their hepatic activities in Wistar rats. What role for oxidative stress?
    Wauthier V; Verbeeck RK; Buc Calderon P
    Arch Toxicol; 2004 Mar; 78(3):131-8. PubMed ID: 14600803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stress-induced changes in the content of cytochrome P450 2E1 in the liver of mice with chronic psychoemotional overexertion].
    Maksymchuk OV; Chashchyn MO
    Fiziol Zh (1994); 2013; 59(4):67-73. PubMed ID: 24175479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for a functional role of cytochrome P450 2E1 in non-alcoholic steatohepatitis.
    Wu CW; Yu J
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1019-20. PubMed ID: 20594211
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alcoholic liver disease: new aspects of studies].
    Tsutsumi M; Takase S
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 1998 Jun; 33(3):171-80. PubMed ID: 9701994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of disease on expression and regulation of CYPs.
    Farrell G
    Mol Aspects Med; 1999; 20(1-2):55-70, 137. PubMed ID: 10575652
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1.
    Wu D; Cederbaum AI
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):70-6. PubMed ID: 16019049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome p-450-mediated differential oxidative modification of proteins: albumin, apolipoprotein E, and CYP2E1 as targets.
    Choi DW; Leininger-Muller B; Wellman M; Kim YH; Siest G
    J Toxicol Environ Health A; 2004 Dec; 67(23-24):2061-71. PubMed ID: 15513903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cytochrome P4502E1 (CYP2E1) activity and hepatic and lymphocyte mRNA expression in patients with chronic hepatitis C.
    Haufroid V; Ligocka D; Wallemacq P; Lison D; Horsmans Y
    Toxicol Lett; 2005 Jan; 155(1):171-7. PubMed ID: 15585372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of non-alcoholic fatty liver].
    Pirlich M; Lochs H; Schmidt HH
    Z Gastroenterol; 2001 May; 39(5):441-2. PubMed ID: 11413919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.